GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anatara Lifesciences Ltd (ASX:ANR) » Definitions » Equity-to-Asset

Anatara Lifesciences (ASX:ANR) Equity-to-Asset : 0.89 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Anatara Lifesciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Anatara Lifesciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$1.27 Mil. Anatara Lifesciences's Total Assets for the quarter that ended in Dec. 2023 was A$1.43 Mil.

The historical rank and industry rank for Anatara Lifesciences's Equity-to-Asset or its related term are showing as below:

ASX:ANR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.65   Med: 0.89   Max: 0.99
Current: 0.89

During the past 9 years, the highest Equity to Asset Ratio of Anatara Lifesciences was 0.99. The lowest was 0.65. And the median was 0.89.

ASX:ANR's Equity-to-Asset is ranked better than
84.09% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs ASX:ANR: 0.89

Anatara Lifesciences Equity-to-Asset Historical Data

The historical data trend for Anatara Lifesciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatara Lifesciences Equity-to-Asset Chart

Anatara Lifesciences Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.93 0.85 0.89 0.77 0.65

Anatara Lifesciences Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.77 0.88 0.65 0.89

Competitive Comparison of Anatara Lifesciences's Equity-to-Asset

For the Biotechnology subindustry, Anatara Lifesciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anatara Lifesciences's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anatara Lifesciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Anatara Lifesciences's Equity-to-Asset falls into.



Anatara Lifesciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Anatara Lifesciences's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Equity to Asset (A: Jun. 2023 )=Total Stockholders Equity/Total Assets
=0.925/1.419
=

Anatara Lifesciences's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1.268/1.431
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anatara Lifesciences  (ASX:ANR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Anatara Lifesciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Anatara Lifesciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Anatara Lifesciences (ASX:ANR) Business Description

Traded in Other Exchanges
N/A
Address
c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000
Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

Anatara Lifesciences (ASX:ANR) Headlines

No Headlines